Fresenius (NYSE:FMS) business group Fresenius Kabi said today that it plans to invest more than $100 million over the next five years in a Wilson, N.C.-based manufacturing site.
The company’s expansion project is designed to boost the facility’s capacity to produce generic medicines in pre-filled syringes, Fresenius reported.
Get the full story at our sister site, Drug Delivery Business News.
The post Fresenius Kabi to invest $100m in North Carolina manufacturing site appeared first on MassDevice.
from MassDevice http://ift.tt/2jd9esg
Cap comentari:
Publica un comentari a l'entrada